1. Clinical predictors of chronic kidney disease in congenital lower urinary tract obstruction.
- Author
-
Katsoufis CP
- Subjects
- Biomarkers blood, Biomarkers urine, Creatinine blood, Fetoscopy, Humans, Renal Insufficiency, Chronic etiology, Ultrasonography, Prenatal, Urinary Bladder Neck Obstruction diagnostic imaging, Urinary Bladder Neck Obstruction embryology, Urinary Tract abnormalities, Urinary Bladder Neck Obstruction pathology
- Abstract
Congenital lower urinary tract obstruction is associated with oligohydramnios and significant perinatal mortality and long-term chronic kidney disease. The counseling of families facing this diagnosis, especially when prenatal intervention is proposed, is fraught with ambiguity. This review aims to equip the provider with the current evidence behind the conventional and novel biomarkers predictive of chronic kidney disease. The relevant clinical predictors are categorized by when they are identified, antenatally or postnatally, and as either anatomic or chemical. They are considered for their prognostic value and the challenges in obtaining them, specifically the risk to the fetus in the case of prenatal biomarkers. Serum creatinine in infancy is the traditional chemical biomarker of kidney function and continues to be a consistent predictor of future serum creatinine. β-2 microglobulin may provide earlier information regarding fetal glomerular and tubular function and is also predictive of long-term serum creatinine. Renal parenchymal area is an anatomic surrogate of nephron mass that is used in both prenatal and postnatal settings. Understanding the anatomic and chemical biomarkers is essential for future refinement of the staging algorithm used to distinguish which patients may benefit from early in utero intervention.
- Published
- 2020
- Full Text
- View/download PDF